Lazard Global Equity Franchise remains a viable choice for investors seeking value-oriented global equities exposure. The team's cohesive, nonhierarchical structure and well-defined investment approach provide a solid foundation in specific sectors. However, its inconsistent track record outside core areas of expertise, exclusion of key market segments, and an unconventional risk-management approach that lacks diversification and strict guardrails contribute to increased risk concentrations and reduced flexibility. These factors underpin our cautious view of the strategy, resulting in an Average rating for People and Process.
Lazard Equity Franchise Portfolio Open Shares LZFOX
- NAV / 1-Day Return $7.71 / −2.28 %
- Fund Size $42.0M
- Adjusted Expense Ratio 1.200%
- Net Expense Ratio 1.200%
- Fee Level: Distribution Average
- Share Class Type No Load
- Morningstar Category Global Small/Mid Stock
- Equity Style Box (Funds) Mid Value
- Minimum Initial Investment $2,500
- Investment Status Open
- TTM Yield 6.46%
- Turnover Ratio 96%
Morningstar’s Analysis LZFOX
Will LZFOX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 49.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Nexi SpA | 6.29 | 2M | Technology |
Omnicom Group Inc | 6.08 | 2M | Communication Services |
Fiserv Inc | 6.06 | 2M | Technology |
FDJ United Ordinary Shares | 6.05 | 2M | Consumer Cyclical |
Cognizant Technology Solutions Corp Class A | 4.89 | 2M | Technology |
H&R Block Inc | 4.81 | 2M | Consumer Cyclical |
Autotrader Group PLC | 4.04 | 2M | Communication Services |
Carl Zeiss Meditec AG | 4.02 | 2M | Healthcare |
Dentsply Sirona Inc | 3.89 | 1M | Healthcare |
Adobe Inc | 3.81 | 1M | Technology |
United States